About Ataraxis AI
Ataraxis is a clinical AI research lab working at the intersection of multi-modal AI and precision medicine. Our goal is to make disease predictable. To accomplish this, we develop new AI methods that predict patient outcomes and treatment response, and build clinical tools to assist physicians in selecting the most optimal treatments for their patients.
Our AI research lab discovers and develops methods to recognize patterns and predict outcomes across complex, multi-modal clinical data. This spans our causality (Ataraxis™ Tau), foundation model (Falcon and Kestrel for digital pathology), and survival analysis research.
Our first clinical products, such as Ataraxis™ Breast for breast cancer, already help patients get the most appropriate treatment across the best academic institutions and community clinics worldwide.
At Ataraxis, you will have a unique opportunity to shape not only the future of our company, but also the future of healthcare. You will join an exceptional team at the forefront of clinical AI research and deployment. Our advisors include AI pioneers such as our founding advisor, Yann LeCun, and distinguished oncologists from top cancer research institutions, all united by the mission to redefine precision medicine.
Ataraxis has raised over $24 million in funding, including a $20 million Series A led by top venture capital funds such as Thiel Capital/Founders Fund (OpenAI, SpaceX, Palantir), Obvious Ventures (AMI Labs, Inceptive, Radical Numerics, Recursion), and AIX Ventures (Hugging Face, Perplexity).
We are an company with a flat organizational structure, where every team member is empowered to actively contribute. Leadership roles are earned by those who demonstrate initiative and consistently deliver exceptional results. Strong work ethic and the ability to prioritize ruthlessly are essential.
Responsibilities
Serve as the primary contact for physicians, labs, hospitals, patients, and internal teams, responding promptly and professionally to all inquiries via phone, email, or web.
Deliver an excellent customer experience by addressing questions about tests, services, billing, and order status with empathy, accuracy, and clear communication.
Collaborate with Sales and clients to resolve missing or incomplete data, ensuring smooth ordering process and and timely delivery of test results.
Maintain detailed and accurate documentation of all communications, actions, and follow-ups.
Research and resolve escalated issues, identify root causes, and communicate outcomes clearly to both customers and internal stakeholders.
Stay knowledgeable about Ataraxis oncology tests, including sample requirements, workflows, and documentation needs.
Support process improvements and special projects that enhance efficiency, quality, or customer satisfaction.
Qualifications
Bachelor’s degree preferred, or an equivalent mix of education and hands-on experience.
1-2+ years of client-facing or customer support experience, ideally within diagnostics, biotech, or healthcare.
Proficient in Salesforce, Microsoft Office, and general data management or CRM systems.
Excellent written and verbal communication skills, with the ability to tailor messaging for physicians, patients, and internal teams.
Strong organizational and time management abilities; able to prioritize multiple tasks in a fast-paced environment.
Demonstrated problem-solving skills with sound judgment and attention to detail.
Works effectively in cross-functional teams, maintaining professionalism and a positive attitude under pressure.
Flexible and adaptable to changing business priorities and operational demands.
Ataraxis AI is a clinical AI research lab developing multi-modal AI methods to predict patient outcomes and treatment response in precision medicine. The company creates AI tools that help physicians select optimal treatments, with research spanning causality analysis (Ataraxis™ Tau), foundation models for digital pathology (Falcon and Kestrel), and survival analysis. Their first clinical product, Ataraxis™ Breast, assists in breast cancer treatment selection and is deployed across academic institutions and community clinics worldwide. The company is backed by prominent venture capital firms including Thiel Capital/Founders Fund and Obvious Ventures, with advisors including AI pioneer Yann LeCun and distinguished oncologists from top cancer research institutions.
